Low-dose trimethoprim-sulfamethoxazole for Pneumocystis jiroveci pneumonia prophylaxis after allogeneic hematopoietic SCT

被引：9

作者：

Muto, T. ^{[1
,2
]}

Takeuchi, M. ^{[1
]}

Kawaguchi, T. ^{[1
,2
]}

Tanaka, S. ^{[1
]}

Tsukamoto, S. ^{[1
]}

Sakai, S. ^{[1
]}

Takeda, Y. ^{[1
]}

Abe, D. ^{[1
]}

Ohwada, C. ^{[1
]}

Sakaida, E. ^{[1
]}

Shimizu, N. ^{[1
,2
]}

Yokote, K. ^{[3
]}

Iseki, T. ^{[1
,2
]}

Nakaseko, C. ^{[1
]}

机构：

[1] Chiba Univ Hosp, Dept Hematol, Chiba, Japan

[2] Chiba Univ Hosp, Div Blood Transfus, Chiba, Japan

[3] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol & Med, Chiba, Japan

来源：

BONE MARROW TRANSPLANTATION | 2011年 / 46卷 / 12期

关键词：

BONE-MARROW-TRANSPLANTATION; CARINII-PNEUMONIA; PREVENTION;

D O I：

10.1038/bmt.2010.335

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：1573 / 1575

页数：3

共 10 条

[1] A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystic carinii pneumonia in human immunodeficiency virus-infected persons [J].

El-Sadr, WM ;

Luskin-Hawk, R ;

Yurik, TM ;

Walker, J ;

Abrams, D ;

John, SL ;

Sherer, R ;

Crane, L ;

Labriola, A ;

Caras, S ;

Pulling, C ;

Hafner, R .

CLINICAL INFECTIOUS DISEASES, 1999, 29 (04) :775-783

[2] Regionally limited or rare infections: prevention after hematopoietic cell transplantation [J].

Gea-Banacloche, J. ;

Masur, H. ;

da Cuhna, C. Arns ;

Chiller, T. ;

Kirchoff, L. ;

Shaw, P. ;

Tomblyn, M. ;

Cordonnier, C. .

BONE MARROW TRANSPLANTATION, 2009, 44 (08) :489-494

[3] Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients [J].

Green, H. ;

Paul, M. ;

Vidal, L. ;

Leibovici, L. .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (03)

[4]

MEYERS JD, 1979, AM REV RESPIR DIS, V120, P1283

[5] High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis [J].

Souza, JP ;

Boeckh, M ;

Gooley, TA ;

Flowers, MED ;

Crawford, SW .

CLINICAL INFECTIOUS DISEASES, 1999, 29 (06) :1467-1471

[6] Pneumocystis pneumonia [J].

Thomas, CF ;

Limper, AH .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (24) :2487-2498

[7] Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective PREFACE [J].

Tomblyn, M. ;

Chiller, T. ;

Einsele, H. ;

Gress, R. ;

Sepkowitz, K. ;

Storek, J. ;

Wingard, J. R. ;

Young, J-A H. ;

Boeckh, M. J. .

BONE MARROW TRANSPLANTATION, 2009, 44 (08) :453-+

[8]

TUAN IZ, 1992, BONE MARROW TRANSPL, V10, P267

[9] Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections [J].

Vasconcelles, MJ ;

Bernardo, MVP ;

King, C ;

Weller, EA ;

Antin, JH .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (01) :35-43

[10] INTERSTITIAL PNEUMONITIS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - 9-YEAR EXPERIENCE AT A SINGLE INSTITUTION [J].

WINGARD, JR ;

MELLITS, ED ;

SOSTRIN, MB ;

CHEN, DYH ;

BURNS, WH ;

SANTOS, GW ;

VRIESENDORP, HM ;

BESCHORNER, WE ;

SARAL, R .

MEDICINE, 1988, 67 (03) :175-186

← 1 →